Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -2.67% | +92.11% | -95.16% |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
Chart calendar Acorda Therapeutics, Inc.
Upcoming events on Acorda Therapeutics, Inc.
Past events on Acorda Therapeutics, Inc.
2024-03-31 | Q4 2023 Earnings Release After hours |
Annual results
Fiscal Period | December | 2019 | 2020 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 192 188 2.16% | 153 149 2.8% |
EBITDA Million USD | Released Forecast Spread | -277 -387 28.4% | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -312 -349 10.62% | -78,1 0,00 - |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -274 -369 25.7% | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | -273 -384 28.91% | -99,6 -40,1 -148.08% |
EPS USD | Released Forecast Spread | -690 -969 28.82% | -246 -97,2 -153.5% |
Announcement Date | 13/02/20 | 04/03/21 |
Past sector events for Acorda Therapeutics, Inc.
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- Calendar Acorda Therapeutics, Inc.